Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Inge van Rooy"'
Autor:
Jos J.M. Drabbels, Erik H. Rozemuller, Robert Welleweerd, Geert W. Haasnoot, Guro M. Johnsen, Inge van Rooy, Anne Cathrine Staff, Michael Eikmans, Frans H.J. Claas, Nienke Westerink
Publikováno v:
Hla
HLA: Immune Response Genetics, 96(2), 179-185. WILEY
HLA: Immune Response Genetics, 96(2), 179-185. WILEY
Polymorphic sites in the HLA-G gene may influence expression and function of the protein. Knowledge of the association between high-resolution HLA-G alleles and 3-prime untranslated (3 ' UTR) haplotypes is useful for studies on the role of HLA-G in t
Autor:
Mihaela Skobe, Catharina de Lange Davies, Inge van Rooy, Sjoerd Hak, Jun Tang, Yiming Zhao, Edward A. Fisher, Zahi A. Fayad, Willem J. M. Mulder, Celso de Mello Donegá, Francois Fay, Andries Meijerink, Aurelian Radu
Publikováno v:
ACS nano, 7(11), 10362-10370. American Chemical Society
In the current study we show the dissociation and tumor accumulation dynamics of dual labeled near infrared (NIR) quantum dot core self-assembled lipidic nanoparticles (SALNPs) in a mouse model upon intravenous administration. Using advanced in vivo
Publikováno v:
European Journal of Pharmaceutical Sciences. 45:330-335
In our previous study, phage display selections were performed by in situ perfusion of a random peptide library through a mouse brain. This yielded two peptides (GLA and GYR) that showed significant binding to human brain endothelial cells (hCMEC/D3)
Autor:
Raymond M. Schiffelers, Heike Dinter-Heidorn, Shin-Ying Wu, Wim E. Hennink, Enrico Mastrobattista, Inge van Rooy, Gert Storm
Publikováno v:
International Journal of Pharmaceutics. 416:448-452
Neurotensin-degrading enzyme (NTDE) inhibitors hold great potential for treating psychotic disorders. However, brain uptake of such compounds in vivo is generally low due to the presence of the blood–brain barrier. In this study, liposomal formulat
Publikováno v:
Nanomedicine. 2:169-181
At present, there are no intravenously administered nucleic acid-based therapeutics that have been approved for human use. This reflects the difficulties in applying nucleic acid-based drugs: they are nuclease sensitive and have difficulties in reach
Autor:
Erik H. Rozemuller, Remco Malestein, Robert Welleweerd, Maarten T. Penning, Hanneke W. M. van Deutekom, Raul Kooter, Inge van Rooy, Job Geerligs, Frans-Paul Ruzius, Michelle van Heck, Pieter Meulenberg
Publikováno v:
Human Immunology. 78:174
Aim HLA genes are the most polymorphic genes in the human genome. The encoded HLA molecules play a pivotal role in generating a target dependent immune response. Several HLA molecules are even associated with a specific disease or drug responsiveness
Autor:
Inge van Rooy, Omid C. Farokhzad, Aneta J. Mieszawska, Canturk Ozcan, David P. Cormode, Artiom Petrov, Zahi A. Fayad, YongTae Kim, Matthew P. Labarre, Bram Priem, Robert Langer, Willem J. M. Mulder, Anita Gianella
Publikováno v:
Bioconjugate chemistry, 24(9), 1429-1434. American Chemical Society
For advanced treatment of diseases such as cancer, multi component, multi functional nanoparticles hold great promise. In the current study we report the synthesis of a complex nanoparticle (NP) system with dual drug loading as well as diagnostic pro
Autor:
Maarten T. Penning, Claudia Rebel, Michelle van Heck, Inge van Rooy, Nienke Westerink, Erik H. Rozemuller
Publikováno v:
Human Immunology. 77:95
Aim Strong association of HLA molecules with autoimmune and inflammatory diseases have been identified, strengthening the value of HLA genetic screening for diagnostic purposes. There’s a strong association between Ankylosing Spondylitis (AS) and H
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 150(1)
In many different studies nanocarriers modified with targeting ligands have been used to target to the brain. Many ligands have been successful, but it is difficult to compare results from different studies to determine which targeting ligand is the
Publikováno v:
International journal of pharmaceutics. 331(2)
Small interfering RNA (siRNA) molecules are the functional mediators of a post-transcriptional gene silencing process known as RNA interference (RNAi). The silencing of genes involved in diseases, using siRNA, is considered a very promising therapeut